Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Interest & Investment Income: 2020-2025

Historic Interest & Investment Income for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to -$562,000.

  • GeneDx Holdings' Interest & Investment Income rose 33.33% to -$562,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 17.96%. This contributed to the annual value of -$3.0 million for FY2024, which is 372.17% down from last year.
  • As of Q3 2025, GeneDx Holdings' Interest & Investment Income stood at -$562,000, which was up 31.21% from -$817,000 recorded in Q2 2025.
  • GeneDx Holdings' 5-year Interest & Investment Income high stood at $1.1 million for Q4 2022, and its period low was -$978,000 during Q4 2023.
  • Moreover, its 3-year median value for Interest & Investment Income was -$640,000 (2025), whereas its average is -$288,182.
  • As far as peak fluctuations go, GeneDx Holdings' Interest & Investment Income skyrocketed by 5,063.64% in 2022, and later crashed by 186.09% in 2023.
  • Over the past 5 years, GeneDx Holdings' Interest & Investment Income (Quarterly) stood at $22,000 in 2021, then soared by 5,063.64% to $1.1 million in 2022, then plummeted by 186.09% to -$978,000 in 2023, then rose by 28.63% to -$698,000 in 2024, then spiked by 33.33% to -$562,000 in 2025.
  • Its Interest & Investment Income was -$562,000 in Q3 2025, compared to -$817,000 in Q2 2025 and -$640,000 in Q1 2025.